Laura Panjwani

November 22, 2016

Optune, a noninvasive device that delivers tumor-treating fields to the brain, had been found to improve efficacy compared to chemotherapy and is well-tolerated by patients with glioblastoma multiforme (GBM).

November 18, 2016

Due to a dramatic reduction of risk for cervical cancer in women who have received the HBV vaccine, there may be a reduction of screening for those women.

November 14, 2016

The incidence of hepatocellular carcinoma (HCC) in patients with hepatitis B is still on the rise, making screening and surveillance in this population all the more important.

November 09, 2016

Brachytherapy is one of three treatments considered standard of care for women with advanced cervical cancer, and it significantly increases the chance of survival. However, less than half of patients with this disease receive standard of care.

November 08, 2016

Dr. Sundar Jagannath discusses the benefits in progression-free survival and quality of life from newly-approved therapies for patients with multiple myeloma.

July 29, 2016

The field of breast cancer has evolved from the days of defaulting to chemotherapy for every patient, yet much work remains to individualize treatment. Though more promising novel regimens have become available, an expert urges clinicians to carefully weigh whether a particular new agent will provide a significant enough benefit to offset its associated toxicities, cost, and the time and commitment by the patient it requires.

June 08, 2016

An analysis of over 28,000 patients younger than 65 with incurable cancers found that approximately three-fourths of them received aggressive care within the last 30 days of life and one-third died in the hospital.

February 04, 2016

Androgen-deprivation therapy, while an effective treatment for prostate cancer, can result in side effects and a reduced quality of life.

September 24, 2015

Rolapitant (Varubi), which was recently approved by the FDA, has been shown to significantly reduce delayed phase CINV when used in combination with other antiemetic agents.

August 26, 2015

For patients with stage III colon cancer, drinking four or more cups of coffee per day may reduce risk of recurrence by 42% and death by 34%.